WHO ICTRP trial
A Study to See if Adding Hydroxychloroquine to Methotrexate Helps Protect the…
CTRI/2025/07/091917 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/07/091917 |
|---|---|
| Public title | A Study to See if Adding Hydroxychloroquine to Methotrexate Helps Protect the Heart in People with Early Rheumatoid Arthritis |
| Scientific title | Cardioprotective Benefits of Methotrexate and Hydroxychloroquine Combination Therapy vs Methotrexate Monotherapy in Early and Low Risk Rheumatoid Arthritis A Randomized Control Study - NIL |
| Primary sponsor | Dr Cyrus Paul Isaac |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified |
| Interventions | Intervention1: Methotrexate and Hydroxychloroquine Therapy: Tablet Methotrexate 7.5mg once a week for 6 months and Tablet Hydroxychloroquine 200mg twice a day daily for 6 months Control Intervention1: Methotrexate Monotherapy: Tablet… |
| Registration date | Jul 28, 2025 |
| Target size | 66 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: